Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Strategic Education Posts Impressive Quarterly Results, Beating Forecasts

Andreas Sommer by Andreas Sommer
September 12, 2025
in Analysis, Earnings
0
Strategic Education Stock
0
SHARES
140
VIEWS
Share on FacebookShare on Twitter

Strategic Education has delivered robust financial performance for the second quarter of 2025, reporting figures that surpassed market expectations. Revenue climbed to $321.5 million, marking a 2.9% year-over-year increase. When adjusted for foreign currency impacts, the growth rate was even stronger at 3.6%. The company’s adjusted earnings per share (EPS) reached $1.52, significantly outpacing the analyst consensus estimate of $1.43. Operating income also saw substantial improvement, rising to $45.8 million. This resulted in an operating margin of 14.2%, a notable expansion from the 13.4% margin reported in the same quarter last year.

A significant driver of this performance was the company’s Education Technology Services (ETS) division, which is undergoing a major transformation. ETS revenue surged by an impressive 49.6% to $36.7 million. This explosive growth was fueled by two primary factors: a nearly 40% jump in subscribers for the Sophia Learning platform and new corporate partnerships secured through its Workforce Edge initiative. The segment’s operating profit soared to $15.0 million, underscoring its increasing contribution to the bottom line.

In contrast, the traditional US Higher Education (USHE) segment experienced a slight headwind. Total student enrollments dipped by 0.8% to 86,339. However, this was partially offset by a record-high proportion of enrollments from employer partners, which reached 31.8%. The Australia/New Zealand (ANZ) division faced more pronounced challenges. Student numbers declined by 3.1%, a decrease largely attributed to recent regulatory changes affecting the international student visa process.

Should investors sell immediately? Or is it worth buying Strategic Education?

  • ETS Revenue Growth: +49.6% to $36.7 million
  • Sophia Learning Subscribers: Increased by nearly 40%
  • USHE Enrollments: -0.8%, but employer partner share hit a record 31.8%
  • ANZ Enrollments: -3.1% due to regulatory headwinds
  • Adjusted EPS: $1.52, beating the $1.43 estimate

Shareholder Returns and Institutional Sentiment

Despite a cautious stance from some major funds, Strategic Education remained committed to returning capital to its shareholders. The company distributed a quarterly cash dividend of $0.60 per share on September 15, 2025. Furthermore, it aggressively repurchased its own stock, buying back 325,844 shares for $28.0 million during Q2. When combined with first-quarter activity, total buybacks for the first half of 2025 reached 717,146 shares, valued at approximately $60.0 million.

This shareholder-friendly activity unfolds against a mixed backdrop of institutional investment. Several large holders reduced their stakes in the first quarter. AQR Capital Management decreased its position by 15.0%, bringing its total holding to 84,993 shares. Other prominent firms, including Blackrock, Vanguard Group, and Marshfield Associates, also trimmed their investments. Conversely, Burgundy Asset Management and Royal Bank of Canada were among those that increased their holdings in the company.

The question remains whether positive analyst sentiment can counterbalance this institutional hesitation. Truist Financial recently reaffirmed its “Buy” rating on the stock. The consensus 12-month price target among analysts continues to suggest significant potential for appreciation from current trading levels.

Ad

Strategic Education Stock: Buy or Sell?! New Strategic Education Analysis from March 25 delivers the answer:

The latest Strategic Education figures speak for themselves: Urgent action needed for Strategic Education investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Strategic Education: Buy or sell? Read more here...

Tags: Strategic Education
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Next Post
IAC/InterActiveCorp Stock

IAC/InterActiveCorp: A Stock Divided Between Optimism and Operational Reality

Chindata Holdings Stock

Bain Capital Divests $4 Billion Chinese Data Center Portfolio in Landmark Deal

Kulicke and Soffa Industries Stock

Kulicke & Soffa Unveils Next-Gen Technology Amid Mixed Financial Results

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com